Acrobiosystems for English
icon_bulk_orderConsulta masiva/Pedido rápido
user
  1. Cuadro de mandos
  2. Mi perfil
  3. Mi dirección
  4. Mis pedidos
  5. Afiliación a Acro
Iniciar sesión Registro
Promotion
Recombinant Proteins ClearClear history
Recombinant Proteins CloseClose
Browse Products By Molecule Name a-zA-Z
TL1A Hot |GMP IL-2 Hot |FcRn Binding Kit (TR-FRET) New |Claudin 18.2
0
No hay productos en el carro de la compra
Mi carro|Check Out
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Casa > DLL3

DLL3

Brief Information

Name:Delta-like protein 3
Target Synonym:Delta-Like Protein 3,Delta3,Delta-Like 3,Drosophila Delta Homolog 3,SCDO1,Delta-Like 3 (Drosophila),DLL3,Delta (Drosophila)-Like 3,Delta Like Canonical Notch Ligand 3
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:13
Lastest Research Phase:NDA/BLA

Antibody Licensing

Project Name Project Stage Molecule Type Host Species Therapeutic Area Indications
DLL3 mAb - 01 Lead Solid Tumor Small cell lung cancer

Product ListCompare or Buy

Product> Filter Results
Por estado del producto :
Por categoría de producto :
Por especies :
Por etiqueta :
Por Conjugado::
Cat. No. Especies Descripción del producto Estructura Pureza Característica
MBS-C018 Human ActiveMax® Human DLL3 μBeads, premium grade (for cells)
SCCHO-ATP111 Human CHO/Human DLL3 Stable Cell Line Development Service
DL3-HA2H3 Human Alexa Fluor™ 647-Labeled Human DLL3 Protein, His TagStar Staining
DL3-HA2H3-structure
DL3-HA2H8 Human APC-Labeled Human DLL3 Protein, His TagStar Staining
DL3-HA2H8-structure
CHEK-ATP090 Human HEK293/Human DLL3 Stable Cell Line
DL3-HP2H7 Human PE-Labeled Human DLL3 Protein, His Tag (Site-specific conjugation)
DL3-HP2H7-structure
DL3-H525x Human Human DLL3 Protein, Llama IgG2b Fc Tag
DL3-H525x-structure
DL3-H525x-sds
DL3-C82E9 Cynomolgus Biotinylated Cynomolgus DLL3 Protein, His,Avitag™
DL3-C82E9-structure
DL3-C82E9-sds
DL3-C52H9 Cynomolgus Cynomolgus DLL3 (27-488) Protein, His Tag
DL3-C52H9-structure
DL3-C52H9-sds
DL3-M52H9 Mouse Mouse DLL3 Protein, His Tag
DL3-M52H9-sds
DL3-H52Hy Human Human DLL3 (176-492) Protein, His Tag
DL3-H52Hy-structure
DL3-H52Hy-sds
DL3-H52Hz Human Human DLL3 (312-492) Protein, His Tag
DL3-H52Hz-structure
DL3-H52Hz-sds
DL3-H52Ha Human Human DLL3 (353-492) Protein, His Tag
DL3-H52Ha-structure
DL3-H52Ha-sds
DL3-H82E4 Human Biotinylated Human DLL3 Protein, His,Avitag™ (MALS verified)
DL3-H82E4-structure
DL3-H82E4-sds
DL3-R52H4 Rhesus macaque Rhesus macaque DLL3 Protein, His Tag
DL3-R52H4-structure
DL3-R52H4-sds
DL3-R52H3 Rat Rat DLL3 Protein, His Tag
DL3-R52H3-structure
DL3-R52H3-sds
DL3-HF2H4 Human FITC-Labeled Human DLL3 Protein, His Tag
DL3-HF2H4-structure
DL3-HF2H4-sds
DL3-C52H3 Cynomolgus Cynomolgus DLL3 Protein, His Tag
DL3-C52H3-structure
DL3-C52H3-sds
DL3-H52H4 Human Human DLL3 Protein, His Tag (MALS verified)
DL3-H52H4-structure
DL3-H52H4-sds
ACRO Quality

Part of Bioactivity data

SCCHO-ATP111-Cell-based assay
DLL3 FACS

Expression analysis of human DLL3 on CHO/Human DLL3 Stable Cell Line by FACS.
Cell surface staining was performed on CHO/Human DLL3 Stable Cell Line or negative control cell using anti-human DLL3 antibody followed by staining with PE anti-human IgG Fc Antibody.

Protocol
CHEK-ATP090-Cell-based assay
DLL3 FACS

Expression analysis of human DLL3 on HEK293/Human DLL3 Stable Cell Line by FACS.
Cell surface staining was performed on HEK293/Human DLL3 Stable Cell Line or negative control cell using anti-human DLL3 antibody followed by staining with PE anti-human IgG Fc antibody.

Protocol
DL3-C52H9-SPR
DLL3 SPR

Bispecific T-cell Engager captured on Protein A Chip can bind Cynomolgus DLL3 (27-488), His Tag (Cat. No. DL3-C52H9) with an affinity constant of 1.02 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).

Protocol
DL3-M52H9-SPR
DLL3 SPR

Bispecific T-cell Engager captured on Protein A Chip can bind Mouse DLL3, His Tag (Cat. No. DL3-M52H9) with an affinity constant of 1.13 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).

Protocol

Synonym Name

Delta3,delta-like 3 (Drosophila),delta-like protein 3,DLL3,Pudgy,SCDO1,SCDO1delta3

Background

Delta-like protein 3 (DLL3) is a transmembrane protein that belongs to the Delta/Serrate/Lag-2 (DSL) family of Notch ligands.May be required to divert neurons along a specific differentiation pathway. Plays a role in the formation of somite boundaries during segmentation of the paraxial mesoderm. DLL3 protein is expressed on the surface of tumor cells but not in normal adult tissues.

Clinical and Translational Updates

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
MK-6070 HPN-328; MK-6070 Phase 2 Clinical Harpoon Therapeutics Small Cell Lung Carcinoma Details
BI-764532 BI-764532; OBT620 Phase 2 Clinical C.H. Boehringer Sohn Ag & Co. Kg Small Cell Lung Carcinoma; Neoplasms; Neuroendocrine Tumors; Carcinoma, Neuroendocrine; Glioma Details
ZG006 ZG006; ZG-006 Phase 2 Clinical Gensun Biopharma Inc, Suzhou Zelgen Biopharmaceuticals Co Ltd Solid tumours; Neoplasms; Small Cell Lung Carcinoma; Carcinoma, Neuroendocrine Details
89Zr-DFO-SC16.56 89Zr-DFO-SC16.56 Phase 1 Clinical Memorial Sloan Kettering Cancer Center Small Cell Lung Carcinoma Details
ZL-1310 ZL-1310; ZL1310; YL212 Phase 1 Clinical Zai Lab (Shanghai) Co Ltd, MediLink Therapeutics Co Ltd Small Cell Lung Carcinoma; Carcinoma, Small Cell Details
FZ-AD005 FZAD005; FZ-AD005 Phase 1 Clinical Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Solid tumours Details
[89Zr]Zr-BI-764532 Phase 1 Clinical C.H. Boehringer Sohn Ag & Co. Kg, Boehringer Ingelheim Gmbh Small Cell Lung Carcinoma; Carcinoma, Neuroendocrine Details
OBT620 OBT620 Phase 1 Clinical Boehringer Ingelheim Gmbh, Oxford Biotherapeutics Ltd Small Cell Lung Carcinoma Details
DLL3-CAR-NK cells Therapy(Tianjin Medical University Cancer Institute and Hospital) DLL3-CAR-NK cells Phase 1 Clinical Tianjin Medical University Cancer Institute And Hospital Small Cell Lung Carcinoma Details
QLS-31904 QLS31904; QLS-31904 Phase 1 Clinical Qilu Pharmaceutical Co Ltd Solid tumours Details
LB-2102(Legend Biotechnology) LB-2102 Phase 1 Clinical Small Cell Lung Carcinoma; Neuroendocrine Tumors Details
PT-217 PT-217 Phase 1 Clinical Phanes Therapeutics Inc Solid tumours; Small Cell Lung Carcinoma; Pancreatic neuroendocrine tumors (pNET); Prostatic Neoplasms; Carcinoma, Neuroendocrine Details
MK-6070 HPN-328; MK-6070 Phase 2 Clinical Harpoon Therapeutics Small Cell Lung Carcinoma Details
BI-764532 BI-764532; OBT620 Phase 2 Clinical C.H. Boehringer Sohn Ag & Co. Kg Small Cell Lung Carcinoma; Neoplasms; Neuroendocrine Tumors; Carcinoma, Neuroendocrine; Glioma Details
ZG006 ZG006; ZG-006 Phase 2 Clinical Gensun Biopharma Inc, Suzhou Zelgen Biopharmaceuticals Co Ltd Solid tumours; Neoplasms; Small Cell Lung Carcinoma; Carcinoma, Neuroendocrine Details
89Zr-DFO-SC16.56 89Zr-DFO-SC16.56 Phase 1 Clinical Memorial Sloan Kettering Cancer Center Small Cell Lung Carcinoma Details
ZL-1310 ZL-1310; ZL1310; YL212 Phase 1 Clinical Zai Lab (Shanghai) Co Ltd, MediLink Therapeutics Co Ltd Small Cell Lung Carcinoma; Carcinoma, Small Cell Details
FZ-AD005 FZAD005; FZ-AD005 Phase 1 Clinical Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Solid tumours Details
[89Zr]Zr-BI-764532 Phase 1 Clinical C.H. Boehringer Sohn Ag & Co. Kg, Boehringer Ingelheim Gmbh Small Cell Lung Carcinoma; Carcinoma, Neuroendocrine Details
OBT620 OBT620 Phase 1 Clinical Boehringer Ingelheim Gmbh, Oxford Biotherapeutics Ltd Small Cell Lung Carcinoma Details
DLL3-CAR-NK cells Therapy(Tianjin Medical University Cancer Institute and Hospital) DLL3-CAR-NK cells Phase 1 Clinical Tianjin Medical University Cancer Institute And Hospital Small Cell Lung Carcinoma Details
QLS-31904 QLS31904; QLS-31904 Phase 1 Clinical Qilu Pharmaceutical Co Ltd Solid tumours Details
LB-2102(Legend Biotechnology) LB-2102 Phase 1 Clinical Small Cell Lung Carcinoma; Neuroendocrine Tumors Details
PT-217 PT-217 Phase 1 Clinical Phanes Therapeutics Inc Solid tumours; Small Cell Lung Carcinoma; Pancreatic neuroendocrine tumors (pNET); Prostatic Neoplasms; Carcinoma, Neuroendocrine Details

This web search service is supported by Google Inc.

totop
Call us
Call us

Germany+49 800 0826645

United Kingdom+44 808 281 3436

Netherlands+31 800 0224992

Switzerland+41 800 040 012

France+33 800 90 78 85

Sweden+46 20 12 76 94

Denmark+45 80 83 07 62

Belgium+32 800 27 125

Email
Correo electrónico
order@acrobiosystems.com
Fax
Fax
+1 888-377-6111
Address
Address
Lichtstrasse 35,4056 Basel, Switzerland
linkedin twitter facebook youtube

Dejar un mensaje

Copyright © 2017 ACROBiosystems. All Rights Reserved
Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap